Cargando…

Prediction of Pubertal Growth at Start of Estrogen Replacement Therapy in Turner Syndrome

In estrogen replacement therapy in Turner syndrome, there is no report which recommends the timing of the start of estrogen therapy in relation to height or adult height prediction. We have established a prediction model for pubertal growth (height difference from the start of estrogen therapy until...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Toshiaki, Horikawa, Reiko, Naiki, Yasuhiro, Yokoya, Susumu, Satoh, Mari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004875/
https://www.ncbi.nlm.nih.gov/pubmed/24790356
http://dx.doi.org/10.1297/cpe.17.9
_version_ 1782314025767403520
author Tanaka, Toshiaki
Horikawa, Reiko
Naiki, Yasuhiro
Yokoya, Susumu
Satoh, Mari
author_facet Tanaka, Toshiaki
Horikawa, Reiko
Naiki, Yasuhiro
Yokoya, Susumu
Satoh, Mari
author_sort Tanaka, Toshiaki
collection PubMed
description In estrogen replacement therapy in Turner syndrome, there is no report which recommends the timing of the start of estrogen therapy in relation to height or adult height prediction. We have established a prediction model for pubertal growth (height difference from the start of estrogen therapy until adult height) at the start of estrogen replacement therapy. Twenty-seven Turner girls without spontaneous puberty were divided into two groups according to birth years; Group I consisted of 16 patients born from 1980–1989 and Group II consisted of 11 patients born before 1980. Using clinical characteristics from Group I, stepwise multiple regression analysis taking pubertal growth as an independent factor, and chronological age, bone age (TW2 RUS method standardized for Japanese children), height and height SDS as dependent factors revealed following formula (p<0.001, R2=0.737): (pubertal growth) = – 1.01x (Chronological age at start of E) – 0.326x (height at start of E) – 1.779x (bone age at start of E) + 90.997. Predicted adult height was obtained by adding predicted pubertal growth to height at the start of estrogen therapy. The mean absolute difference between real adult height (tallest height after height velocity less than 1 cm/yr) and predicted adult height was 1.6 ± 0.9 cm (0.3–2.8 cm) in Group I. When this prediction model was applied to Group II, The mean absolute difference between real adult height and predicted adult height was 1.0 ± 0.7 cm (0.1–2.0 cm). A prediction model for pubertal growth at start of estrogen therapy in Turner syndrome was obtained. Using this prediction model, the timing of the start of estrogen therapy can be decided in consideration of the patient’s desired adult height.
format Online
Article
Text
id pubmed-4004875
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher The Japanese Society for Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-40048752014-04-30 Prediction of Pubertal Growth at Start of Estrogen Replacement Therapy in Turner Syndrome Tanaka, Toshiaki Horikawa, Reiko Naiki, Yasuhiro Yokoya, Susumu Satoh, Mari Clin Pediatr Endocrinol Original In estrogen replacement therapy in Turner syndrome, there is no report which recommends the timing of the start of estrogen therapy in relation to height or adult height prediction. We have established a prediction model for pubertal growth (height difference from the start of estrogen therapy until adult height) at the start of estrogen replacement therapy. Twenty-seven Turner girls without spontaneous puberty were divided into two groups according to birth years; Group I consisted of 16 patients born from 1980–1989 and Group II consisted of 11 patients born before 1980. Using clinical characteristics from Group I, stepwise multiple regression analysis taking pubertal growth as an independent factor, and chronological age, bone age (TW2 RUS method standardized for Japanese children), height and height SDS as dependent factors revealed following formula (p<0.001, R2=0.737): (pubertal growth) = – 1.01x (Chronological age at start of E) – 0.326x (height at start of E) – 1.779x (bone age at start of E) + 90.997. Predicted adult height was obtained by adding predicted pubertal growth to height at the start of estrogen therapy. The mean absolute difference between real adult height (tallest height after height velocity less than 1 cm/yr) and predicted adult height was 1.6 ± 0.9 cm (0.3–2.8 cm) in Group I. When this prediction model was applied to Group II, The mean absolute difference between real adult height and predicted adult height was 1.0 ± 0.7 cm (0.1–2.0 cm). A prediction model for pubertal growth at start of estrogen therapy in Turner syndrome was obtained. Using this prediction model, the timing of the start of estrogen therapy can be decided in consideration of the patient’s desired adult height. The Japanese Society for Pediatric Endocrinology 2008-02-14 2008 /pmc/articles/PMC4004875/ /pubmed/24790356 http://dx.doi.org/10.1297/cpe.17.9 Text en 2008©The Japanese Society for Pediatric Endocrinology http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License.
spellingShingle Original
Tanaka, Toshiaki
Horikawa, Reiko
Naiki, Yasuhiro
Yokoya, Susumu
Satoh, Mari
Prediction of Pubertal Growth at Start of Estrogen Replacement Therapy in Turner Syndrome
title Prediction of Pubertal Growth at Start of Estrogen Replacement Therapy in Turner Syndrome
title_full Prediction of Pubertal Growth at Start of Estrogen Replacement Therapy in Turner Syndrome
title_fullStr Prediction of Pubertal Growth at Start of Estrogen Replacement Therapy in Turner Syndrome
title_full_unstemmed Prediction of Pubertal Growth at Start of Estrogen Replacement Therapy in Turner Syndrome
title_short Prediction of Pubertal Growth at Start of Estrogen Replacement Therapy in Turner Syndrome
title_sort prediction of pubertal growth at start of estrogen replacement therapy in turner syndrome
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004875/
https://www.ncbi.nlm.nih.gov/pubmed/24790356
http://dx.doi.org/10.1297/cpe.17.9
work_keys_str_mv AT tanakatoshiaki predictionofpubertalgrowthatstartofestrogenreplacementtherapyinturnersyndrome
AT horikawareiko predictionofpubertalgrowthatstartofestrogenreplacementtherapyinturnersyndrome
AT naikiyasuhiro predictionofpubertalgrowthatstartofestrogenreplacementtherapyinturnersyndrome
AT yokoyasusumu predictionofpubertalgrowthatstartofestrogenreplacementtherapyinturnersyndrome
AT satohmari predictionofpubertalgrowthatstartofestrogenreplacementtherapyinturnersyndrome